ANGIOPOIETIN-2Biomarker1 paperHumans1LatestNov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 0Sep 2026: 2Oct 2026: 14Research SquareHumansPreprint·10 hEndothelial and oxidative biomarker profiles in atrial fibrillation according to SGLT2 inhibitor exposure: a cross-sectional studyBiomarkersBiomoleculesReview·26 SepTissue-Specific Angiogenic Responses to Exercise: Mechanisms and Research AdvancesExerciseDiabetes, Obesity & MetabolismReview·3 SepSodium-Glucose Cotransporter 2 Inhibition in Diabetic Macular Oedema: Emerging Evidence for Stage-Dependent Systemic-Retinal ResponsivenessSGLT2 inhibitorsADA Scientific Sessions 2026 AbstractHuman trial·8 JunSerum Proteomics Suggest Novel Mechanisms of Action of Semaglutide in Reducing the Risk of MACE in the SELECT TrialInterventions
Research SquareHumansPreprint·10 hEndothelial and oxidative biomarker profiles in atrial fibrillation according to SGLT2 inhibitor exposure: a cross-sectional studyBiomarkers
BiomoleculesReview·26 SepTissue-Specific Angiogenic Responses to Exercise: Mechanisms and Research AdvancesExercise
Diabetes, Obesity & MetabolismReview·3 SepSodium-Glucose Cotransporter 2 Inhibition in Diabetic Macular Oedema: Emerging Evidence for Stage-Dependent Systemic-Retinal ResponsivenessSGLT2 inhibitors
ADA Scientific Sessions 2026 AbstractHuman trial·8 JunSerum Proteomics Suggest Novel Mechanisms of Action of Semaglutide in Reducing the Risk of MACE in the SELECT TrialInterventions